Complement receptor 1-related gene/protein-y (Crry) is a rodent structural and functional analog of CR1, and a CR2-Crry construct administered 90 min after ischemia in a murine MCAO model was shown to improve survival, reduce infarct volume, reduce P-selectin expression and neutrophil recruitment, and improve neurological outcome. Here, SELP is linked to ischemia.